Cedar Mountain Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Other funds holding KRYS
Cedar Mountain Advisors's KRYS Position: Q3 2026 in Review
Cedar Mountain Advisors sold out of Krystal Biotech (KRYS) in Q3 2026, closing a stake of 3 shares — an estimated $1.12K sold.
Cedar Mountain Advisors first reported a position in KRYS in Q1 2026 and held it in 2 quarters. The position peaked at $1.12K in Q2 2026. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.
- Cedar Mountain Advisors reported no remaining Krystal Biotech position as of Q3 2026 after selling out during the quarter.
- Cedar Mountain Advisors sold 3 Krystal Biotech shares in Q3 2026, an estimated $1.12K.
- Cedar Mountain Advisors first reported a position in Krystal Biotech in Q1 2026 and held it in 2 quarters.
- Cedar Mountain Advisors's Krystal Biotech position peaked at $1.12K in Q2 2026.
- 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.
Based on Cedar Mountain Advisors's 13F filing for Q3 2026, filed 15 Oct 2026.